CTTI is pleased to announce the addition of a leader in the National Institutes of Health’s (NIH) research initiatives to its Executive Committee, as well as the renewal of the appointments of three current members.

New EC member Jodi Black is the deputy director of the NIH Office of Extramural Research, where she oversees and supports initiative development, grants management policy and processes, and the small business and extramural technology development programs.

“CTTI’s work relies on input, participation, and collaboration across a range of public and private stakeholders in clinical research and development,” said CTTI Executive Director Pamela Tenaerts. “Jodi’s passion for challenging the status quo, as well as her experience building strategic alliances between academia, healthcare, and industry, will be invaluable to furthering CTTI’s efforts and advancing our mission to improve the efficiency and quality of clinical trials.”

CTTI is also delighted to extend the terms of current members Hans-Georg Eichler of the European Medicines Agency (until Dec. 31, 2020), Dalvir Gill of TransCelerate BioPharma Inc. (until Dec. 31, 2019), and Louis Jacques of ADVI (until Dec. 31, 2018).

“We are grateful for the continued commitment of Hans-Georg, Dalvir, and Louis, and excited for the valuable expertise Jodi brings to our committee,” said CTTI Executive Committee Chair Mark McClellan. “I’m confident that their leadership and insight will significantly contribute to the overall direction and strategy of CTTI and its impact on clinical research.”